Previously, it was documented that IL-6 is capable of suppressing replication of HBV together with inhibiting the accumulation of HBV-covalently closed circular DNA (ccc DNA) in human hepatoma cells [29]. This evidence concerns the gene IL6 and hepatocellular carcinoma.